306 related articles for article (PubMed ID: 36118413)
1. A contemporary snippet on clinical presentation and management of toxic epidermal necrolysis.
Naik PP
Scars Burn Heal; 2022; 8():20595131221122381. PubMed ID: 36118413
[TBL] [Abstract][Full Text] [Related]
2. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.
Schneider JA; Cohen PR
Adv Ther; 2017 Jun; 34(6):1235-1244. PubMed ID: 28439852
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Combination Therapy With Etanercept and Systemic Corticosteroids for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Observational Study.
Zhang J; Lu CW; Chen CB; Wang CW; Chen WT; Cheng B; Ji C; Chung WH
J Allergy Clin Immunol Pract; 2022 May; 10(5):1295-1304.e6. PubMed ID: 35131514
[TBL] [Abstract][Full Text] [Related]
4. Management of Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis: Looking Beyond Guidelines!
Kumar R; Das A; Das S
Indian J Dermatol; 2018; 63(2):117-124. PubMed ID: 29692452
[TBL] [Abstract][Full Text] [Related]
5. Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective.
Gupta LK; Martin AM; Agarwal N; D'Souza P; Das S; Kumar R; Pande S; Das NK; Kumaresan M; Kumar P; Garg A; Singh S
Indian J Dermatol Venereol Leprol; 2016; 82(6):603-625. PubMed ID: 27716721
[TBL] [Abstract][Full Text] [Related]
6. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Diagnosis and Management.
Frantz R; Huang S; Are A; Motaparthi K
Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577817
[TBL] [Abstract][Full Text] [Related]
7. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T
Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475
[TBL] [Abstract][Full Text] [Related]
8. A meta-analysis of cyclosporine treatment for Stevens-Johnson syndrome/toxic epidermal necrolysis.
Ng QX; De Deyn MLZQ; Venkatanarayanan N; Ho CYX; Yeo WS
J Inflamm Res; 2018; 11():135-142. PubMed ID: 29636627
[TBL] [Abstract][Full Text] [Related]
9. High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases.
Chen J; Wang B; Zeng Y; Xu H
Eur J Dermatol; 2010; 20(6):743-7. PubMed ID: 20952352
[TBL] [Abstract][Full Text] [Related]
10. Toxic Epidermal Necrolysis: A Review of Past and Present Therapeutic Approaches.
Singh N; Phillips M
Skin Therapy Lett; 2022 Sep; 27(5):7-13. PubMed ID: 36469487
[TBL] [Abstract][Full Text] [Related]
11. Intravenous Immunoglobulin Combined With Corticosteroids for the Treatment of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Propensity-Matched Retrospective Study in China.
Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH
Front Pharmacol; 2021; 12():750173. PubMed ID: 35115922
[No Abstract] [Full Text] [Related]
12. Recent Dermatological Treatments for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Japan.
Hsieh MH; Watanabe T; Aihara M
Front Med (Lausanne); 2021; 8():636924. PubMed ID: 34395458
[TBL] [Abstract][Full Text] [Related]
13. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the Era of Systems Medicine.
Chen CB; Wang CW; Chung WH
Methods Mol Biol; 2022; 2486():37-54. PubMed ID: 35437717
[TBL] [Abstract][Full Text] [Related]
14. A Bayesian Network Meta-Analysis of the Effect of Targeted Therapies on the Total Length of Hospital Stay in Children with Drug-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Syndrome.
Ozerturk S; Derici Yildirim D; Arikoglu T; Kuyucu S; Kont Ozhan A
Pediatr Allergy Immunol Pulmonol; 2024 Mar; 37(1):22-32. PubMed ID: 38484271
[No Abstract] [Full Text] [Related]
15. Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Aihara M; Kano Y; Fujita H; Kambara T; Matsukura S; Katayama I; Azukizawa H; Miyachi Y; Endo Y; Asada H; Miyagawa F; Morita E; Kaneko S; Abe R; Ochiai T; Sueki H; Watanabe H; Nagao K; Aoyama Y; Sayama K; Hashimoto K; Shiohara T;
J Dermatol; 2015 Aug; 42(8):768-77. PubMed ID: 25982480
[TBL] [Abstract][Full Text] [Related]
16. Stevens-Johnson syndrome and toxic epidermal necrolysis: a 10-year experience in a burns unit.
Houschyar KS; Tapking C; Borrelli MR; Nietzschmann I; Puladi B; Ooms M; Rein S; Houschyar M; Duscher D; Maan ZN; Reumuth G; Branski LK; Modabber A; Kluwig D; Schmitt L; Philipp-Dormston WG; Yazdi AS; Siemers F
J Wound Care; 2021 Jun; 30(6):492-496. PubMed ID: 34121430
[TBL] [Abstract][Full Text] [Related]
17. Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.
Houschyar KS; Tapking C; Borrelli MR; Puladi B; Ooms M; Wallner C; Duscher D; Pförringer D; Rein S; Reumuth G; Schulz T; Nietzschmann I; Maan ZN; Grieb G; Philipp-Dormston WG; Branski LK; Siemers F; Lehnhardt M; Schmitt L; Yazdi AS
J Wound Care; 2021 Dec; 30(12):1012-1019. PubMed ID: 34881995
[TBL] [Abstract][Full Text] [Related]
18. Stevens-Johnson Syndrome and toxic epidermal necrolysis: a multi-aspect comparative 7-year study from the People's Republic of China.
Sun J; Liu J; Gong QL; Ding GZ; Ma LW; Zhang LC; Lu Y
Drug Des Devel Ther; 2014; 8():2539-47. PubMed ID: 25548516
[TBL] [Abstract][Full Text] [Related]
19. [Drug-induced toxic epidermal necrolysis with secondary aspergillus fumigatus infection: a case report].
Zhang S; Liu XY; Zhang JZ; Cai L; Zhou C
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Oct; 51(5):977-980. PubMed ID: 31624410
[TBL] [Abstract][Full Text] [Related]
20. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
